Susquehanna International Group, LLP Evolus, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Evolus, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 49,829 shares of EOLS stock, worth $603,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,829

Previous 15,868 214.02%

Holding current value

$603,429

Previous $172,000 369.19%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.66 - $17.48 $362,024 - $593,638	33,961 Added 214.02%	49,829 $807,000
Q2 2024 Aug 15, 2024	SELL	$10.45 - $13.76 $2.95 Million - $3.89 Million	-282,490 Reduced 94.68%	15,868 $172,000
Q1 2024 May 07, 2024	BUY	$9.99 - $14.91 $2.84 Million - $4.23 Million	283,962 Added 1972.51%	298,358 $4.18 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $31,441 - $43,562	-4,137 Reduced 22.32%	14,396 $151,000
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $83,118 - $118,574	-11,625 Reduced 38.55%	18,533 $169,000
Q2 2023 Aug 11, 2023	BUY	$7.23 - $10.52 $22,376 - $32,559	3,095 Added 11.44%	30,158 $219,000
Q1 2023 May 16, 2023	BUY	$7.81 - $11.05 $94,907 - $134,279	12,152 Added 81.5%	27,063 $228,000
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.95 $212,982 - $292,360	-32,666 Reduced 68.66%	14,911 $111,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $369,197 - $652,756	47,577 New	47,577 $383,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $259,494 - $404,946	-48,323 Reduced 25.01%	144,908 $943,000
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $762,113 - $1.42 Million	-103,548 Reduced 34.89%	193,231 $1.47 Million
Q2 2021 Aug 11, 2021	BUY	$8.42 - $13.96 $1.78 Million - $2.95 Million	211,250 Added 246.99%	296,779 $3.75 Million
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $685,772 - $3.54 Million	-214,304 Reduced 71.47%	85,529 $1.11 Million
Q4 2020 Feb 16, 2021	BUY	$2.92 - $4.84 $696,160 - $1.15 Million	238,411 Added 388.15%	299,833 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$3.03 - $5.48 $40,935 - $74,034	-13,510 Reduced 18.03%	61,422 $240,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $89,386 - $156,236	25,322 Added 51.04%	74,932 $397,000
Q1 2020 May 15, 2020	SELL	$3.53 - $12.21 $120,775 - $417,752	-34,214 Reduced 40.82%	49,610 $206,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $495,635 - $743,453	-42,801 Reduced 33.8%	83,824 $1.02 Million
Q3 2019 Nov 14, 2019	BUY	$13.91 - $19.87 $839,468 - $1.2 Million	60,350 Added 91.06%	126,625 $1.98 Million
Q2 2019 Aug 16, 2019	BUY	$13.19 - $28.36 $49,449 - $106,321	3,749 Added 6.0%	66,275 $969,000
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $1.08 Million - $2.32 Million	-81,760 Reduced 56.67%	62,526 $914,000
Q1 2019 May 15, 2019	BUY	$12.43 - $28.91 $1.29 Million - $3 Million	103,855 Added 256.87%	144,286 $3.26 Million
Q4 2018 Feb 14, 2019	BUY	$10.57 - $19.29 $427,355 - $779,913	40,431 New	40,431 $481,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $679M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Evolus, Inc. Transaction History